Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: A phase II-III clinical trial-Reference-Cited by-同舟云学术

Efficacy and safety of concurrent chemoradiation with weekly cisplatin ± low-dose celecoxib in locally advanced undifferentiated nasopharyngeal carcinoma: A phase II-III clinical trial

Published:2011 Issue:4 Volume:7 Page:442
ISSN:0973-1482
Container-title:Journal of Cancer Research and Therapeutics
language:en
Short-container-title:J Can Res Ther

Author:

Mohamma-Dianpanah Mohammad,Shafizad Amin,Khademi Bijan,Ansari Mansour,Mosalaei Ahmad,Razmjou-Ghalaei Sasan,Ashouri-Taziani Yaghoub,Ahmadloo Niloofar,Omidvari Shapour,Mosleh-Shirazi MohammadAmin

Publisher

Medknow

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Celecoxib in Addition to Standard Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Current Oncology;2022-08-25

2. Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies;Current Oncology;2021-11-21

3. The Efficacy of Celecoxib During Chemoradiation in Locally Advanced Head and Neck Carcinoma; A Phase 2 Randomized Placebo-Controlled Clinical Trial;International Journal of Cancer Management;2021-06-12

4. Cyclooxygenase‑2 expression is associated with chemoresistance through cancer stemness property in hypopharyngeal carcinoma;Oncology Letters;2021-05-17

5. Head and neck cancer and non‐steroidal anti‐inflammatory drugs: Systematic review and meta‐analysis;Head & Neck;2021-03-08